drugset / Trial / NCT04620382

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

NCT04620382

RandomizedCrossoverSingle-blindOther

Summary

The purpose of this study is to learn more about the effects of abdominal compression and the medication midodrine, two interventions used for the treatment of orthostatic hypotension (low blood pressure on standing), on hemodynamic markers of cardiovascular risk. The study will be conducted at the Vanderbilt University Medical Center and consists of a screening and 2 testing days, one with abdominal compression and one with midodrine. The total length of the study will be about 5 days.

Timeline

Start
2020-11-09
Primary completion
2025-07-01
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Midodrine Small molecule 5 mg Oral
Comparator Midodrine Small molecule 10 mg Oral